United States: Dihexa is not classified as a prescription drug, dietary supplement, or approved therapy
The method according to claim 1 or 2, the use according to any one of claims 3-6, or the composition according to claim 7 or 8, wherein the subject is a subject which has been identified as being a responder to treatment with the composition
Consistent with these gene expression changes, SREBP-2 siRNA transfection reduced HMGCR protein expression compared with un-transfected groups (Fig
Why This Matters: A Quick Primer on Section 503A Under Section 503A of the Federal Food, Drug, and Cosmetic Act (FD&C Act), human drug products compounded by a licensed pharmacist in a state-licensed pharmacy or by a licensed physician can be exempt from three major FDA requirements: current Good Manufacturing Practice (cGMP) standards, certain labeling requirements, and the standard new drug approval process (NDAs/ANDAs)